DISA    Last:0.001   -

Big Break thru for Equition

Its just the beginning for Disa... Looking forward for more Big events...🚀 🚀 🚀

 

Not many people know how to use the machine , machine will be spoil regularly and and testing will be distrupted.. look at the machine for the free face masks , always downed and waiting for the man to repair or adjust .

bornloser      ( Date: 21-Jan-2022 09:57) Posted: Let BBs shout buy and buy. Today test negative does not mean tomorrow and day after still free from COVID How much time and money need to be spent?

 

8 buyers nonstop....

shorties might have to cut 9/10 later.......

 

Let BBs shout buy and buy. Today test negative does not mean tomorrow and day after still free from COVID How much time and money need to be spent?

 

Another wayang show by Eddie to justify his million$ salary. Not practical at all to installs machine for testing. Too slow , all will jam up , no need to go to work or office ? Spend time to wait for such testing homm8c ?

nqing87      ( Date: 20-Jan-2022 17:34) Posted: Hmmm.. 10 to 15 test per hr per machine is quite slow.. thousands of ppl moving around and it won't be feasible to put hundreds of machines to test the ppl quickly

 

Cannot even make enough to cover Eddie remunerations

bernardc      ( Date: 21-Jan-2022 08:25) Posted: Slow..not if you millions placed all over the world..eg in sg placed in clinics. Eg.. nqing87      ( Date: 20-Jan-2022 17:34) Posted: Hmmm.. 10 to 15 test per hr per machine is quite slow.. thousands of ppl moving around and it won't be feasible to put hundreds of machines to test the ppl quickly

 

Slow..not if you millions placed all over the world..eg in sg placed in clinics. Eg..

nqing87      ( Date: 20-Jan-2022 17:34) Posted: Hmmm.. 10 to 15 test per hr per machine is quite slow.. thousands of ppl moving around and it won't be feasible to put hundreds of machines to test the ppl quickly

 

after next week, the trial will start ....

not jz covid tests...later will expand to other clinical tests as well..

looking good..siah

 

Someone said ART kit might cost RM 4.90 in Malaysia. Can do it own time. Own location. Can stock up. Can transferable.

 

The Automated Machine can be deployed at dormitories, MICE, airports, train stations, hotels, schools, stadiums etc.

 

Hmmm.. 10 to 15 test per hr per machine is quite slow.. thousands of ppl moving around and it won't be feasible to put hundreds of machines to test the ppl quickly

 

Slowly chipping off the 9 wall
Scrapers and contras stay off
Only for genuine collectors
Once 9 clear, touch 10 and the
PSAR dot reversed and we are ready for
Wave 5
Technical view 12/13 hopefully by next week
Just nice before cny
Huat to all Disa-ians

 

DISA DIGITAL SAFETY PTE. LTD. SIGNED PROOF OF CONCEPT AGREEMENTS
WITH PRIVATE HEALTHCARE SERVICE PROVIDERS TO TEST
ITS AUTOMATED ANTIGEN RAPID TEST (' ART' ) MACHINE

Disa Digital Safety Pte. Ltd. has signed proof of concept
agreements, through its 40% owned associate company, Digital Life Line Pte. Ltd. (' DLL' ), with
two large Singapore based private healthcare service providers to test the scalability of its patent
pending Automated Antigen Rapid Test (' ART' ) System (' Automated Machine' ) in February
2022.

The Automated Machine hastens the entire ART process which enables service providers to
provide more tests within a shorter period. The automation will also enable our partners to
overcome the shortage of manpower. The digitalisation will also help to cope with the increasing
ART tests volume in view of the fast spreading Omicron variant.
The Automated Machine can be deployed at dormitories, MICE, airports, train stations, hotels,
schools, stadiums etc.

' We are pleased to test our technology in Singapore. Through partnerships with the healthcare
service providers, we hope to expand this automation system regionally. The automated system
can be used for any type of lateral flow point of care and not limited to only COVID-19' , said Mr
Eddie Chng, the Managing Director and CEO of DLL.

DLL has licensed the saliva-based ART kit IP from Duke-NUS Medical School and SingHealth.
The kit, known as Parallel Amplified Saliva rapid POint-of-caRe Test (PASPORT), uses
nanoparticles to bind the virus and uniquely. It also adds as a second type of nanoparticle that
binds the first set of nanoparticles to amplify the signal. This makes testing using PASPORT
The Automated Machine requires users to self-register by scanning
their NRIC or passport at the kiosk. Users are then required to scan
the unique QR code on the ART kit on the Automated Machine to
uniquely tag the ART kit to the user for track and trace purposes.
Users will perform the test in front of the Automated Machine in
accordance to the test steps as illustrated on the screen of the
Automated Machine. Users can then insert the ART cassette into the
Automated Machine and leave without having to wait for the test
result. The entire process is video recorded and takes no more than
5 minutes for each user. The Automated Machine will take a photo
of the ART cassette and the results are sent automatically and
digitally to the rightful owners within 15 to 20 minutes after the test is
completed.

Each Automated Machine can handle about 10 to 15 tests per hour,
operating for 24 hours a day. With the use of the Automated
Machine, ART tests can be processed faster. Video recording
guarantees the authenticity of the tests. Most importantly, all the
ART test results cannot be tampered with as the ART cassette will
have to be inserted into the Automated Machine before the result
appears. more sensitive at finding and flagging the virus and allows it to be used at any time of the day,
where the sensitivity of the test is not compromised even after eating or drinking. Compared to
other ART, amplification enables PASPORT to be extremely sensitive. In a clinical study
involving over 100 participants conducted at SGH, PASPORT&rsquo s sensitivity in detecting the virus
was 97% and its specificity at 90.6%, compared to the gold standard PCR test. The invention
was reviewed and published by Microchimica Acta* in November 2021
 

 

Looks very ' ho liao'....

LowLow12      ( Date: 20-Jan-2022 07:38) Posted: NEWS RELEASE: DISA DIGITAL SAFETY PTE. LTD. SIGNED PROOF OF CONCEPT AGREEMENTS WITH PRIVATE HEALTHCARE SERVICE PROVIDERS TO TEST ITS AUTOMATED ANTIGEN RAPID TEST (?ART?) MACHINE SINGAPORE ? January 20, 2022 ? Disa Digital Safety Pte. Ltd. has signed proof of concept agreements, through its 40% owned associate company, Digital Life Line Pte. Ltd. (?DLL?), with two large Singapore based private healthcare service providers to test the scalability of its patent pending Automated Antigen Rapid Test (?ART?) System (?Automated Machine?) in February 2022. The Automated Machine requires users to self-register by scanning their NRIC or passport at the kiosk. Users are then required to scan the unique QR code on the ART kit on the Automated Machine to uniquely tag the ART kit to the user for track and trace purposes. Users will perform the test in front of the Automated Machine in accordance to the test steps as illustrated on the screen of the Automated Machine. Users can then insert the ART cassette into the Automated Machine and leave without having to wait for the test result. The entire process is video recorded and takes no more than 5 minutes for each user. The Automated Machine will take a photo of the ART cassette and the results are sent automatically and digitally to the rightful owners within 15 to 20 minutes after the test is completed. Each Automated Machine can handle about 10 to 15 tests per hour, operating for 24 hours a day. With the use of the Automated Machine, ART tests can be processed faster. Video recording guarantees the authenticity of the tests. Most importantly, all the ART test results cannot be tampered with as the ART cassette will have to be inserted into the Automated Machine before the result appears. The Automated Machine hastens the entire ART process which enables service providers to provide more tests within a shorter period. The automation will also enable our partners to overcome the shortage of manpower. The digitalisation will also help to cope with the increasing ART tests volume in view of the fast spreading Omicron variant. The Automated Machine can be deployed at dormitories, MICE, airports, train stations, hotels, schools, stadiums etc. ?We are pleased to test our technology in Singapore. Through partnerships with the healthcare service providers, we hope to expand this automation system regionally. The automated system can be used for any type of lateral flow point of care and not limited to only COVID-19?, said Mr Eddie Chng, the Managing Director and CEO of DLL. DLL has licensed the saliva-based ART kit IP from Duke-NUS Medical School and SingHealth. The kit, known as Parallel Amplified Saliva rapid POint-of-caRe Test (PASPORT), uses nanoparticles to bind the virus and uniquely. It also adds as a second type of nanoparticle that binds the first set of nanoparticles to amplify the signal. This makes testing using PASPORT more sensitive at finding and flagging the virus and allows it to be used at any time of the day, where the sensitivity of the test is not compromised even after eating or drinking. Compared to other ART, amplification enables PASPORT to be extremely sensitive. In a clinical study involving over 100 participants conducted at SGH, PASPORT?s sensitivity in detecting the virus was 97% and its specificity at 90.6%, compared to the gold standard PCR test. The invention was reviewed and published by Microchimica Acta* in November 2021. *Microchimica Acta, established in 1937 by Fritz Pregl, is a monthly peer-reviewed scientific journal published by Springer Nature. About Digital Life Line Pte. Ltd. DLL, a 40% owned associate company of Disa Digital Safety Pte. Ltd., is a Singapore-based company that deals with the manufacturing and distribution of saliva-based Antigen Rapid Test (ART) kits. DLL has signed tri-party licensing agreement with National University of Singapore (?NUS?) and Singapore Health Services Pte. Ltd. (?SingHealth?) on 8 December 2021 for the use of their new saliva-based COVID-19 ART technology. This technology was co-developed by SingHealth Duke-NUS Academic Medical Centre and the NUS. About DiSa Digital Safety Pte. Ltd. DiSa, a wholly-owned subsidiary of DISA Limited, is a Singapore-based technology solution provider that specializes in research and development of cutting-edge digital security solution (?DiSa Asset Protection System?). With its single scan technology and seamless integration, DiSa has been able to provide item level tracking and data with no disruption to the sales process. This technology is now protecting products and categories previously unachievable with traditional serialization methods, saving millions of dollars in prevented returns. DiSa entered the US market in 2014 launching its Smart Solutions within the largest retailer in the world with a limited store test. After rigorous testing by the Loss Prevention Research Council, USA, DiSa rolled out its Smart Solutions nationwide in 2017. About DISA Limited DISA Limited (SGX: 532), is a publicly-traded company on the Singapore Catalist Stock Exchange. More information is available at http://www.digital-safety.com.

 

👍 🚀 🚀 🚀 .... Lets go go go...

LowLow12      ( Date: 20-Jan-2022 07:43) Posted: Wave 5 coming Target 12/13 wave 5 The wall of 10 shall be tear down Next news will be license by HSA and MOH Disa will fly to the moon Fingers cross Toes cross

 

Wave 5 coming
Target 12/13 wave 5
The wall of 10 shall be tear down
Next news will be license by HSA and MOH
Disa will fly to the moon

Fingers cross
Toes cross

 

NEWS RELEASE:
DISA DIGITAL SAFETY PTE. LTD. SIGNED PROOF OF CONCEPT AGREEMENTS WITH PRIVATE HEALTHCARE SERVICE PROVIDERS TO TEST ITS AUTOMATED ANTIGEN RAPID TEST (?ART?) MACHINE
SINGAPORE ? January 20, 2022 ? Disa Digital Safety Pte. Ltd. has signed proof of concept agreements, through its 40% owned associate company, Digital Life Line Pte. Ltd. (?DLL?), with two large Singapore based private healthcare service providers to test the scalability of its patent pending Automated Antigen Rapid Test (?ART?) System (?Automated Machine?) in February 2022.
The Automated Machine requires users to self-register by scanning their NRIC or passport at the kiosk. Users are then required to scan the unique QR code on the ART kit on the Automated Machine to uniquely tag the ART kit to the user for track and trace purposes.
Users will perform the test in front of the Automated Machine in accordance to the test steps as illustrated on the screen of the Automated Machine. Users can then insert the ART cassette into the Automated Machine and leave without having to wait for the test result. The entire process is video recorded and takes no more than 5 minutes for each user. The Automated Machine will take a photo of the ART cassette and the results are sent automatically and digitally to the rightful owners within 15 to 20 minutes after the test is completed.
Each Automated Machine can handle about 10 to 15 tests per hour, operating for 24 hours a day. With the use of the Automated Machine, ART tests can be processed faster. Video recording guarantees the authenticity of the tests. Most importantly, all the ART test results cannot be tampered with as the ART cassette will have to be inserted into the Automated Machine before the result appears.
The Automated Machine hastens the entire ART process which enables service providers to provide more tests within a shorter period. The automation will also enable our partners to overcome the shortage of manpower. The digitalisation will also help to cope with the increasing ART tests volume in view of the fast spreading Omicron variant.
The Automated Machine can be deployed at dormitories, MICE, airports, train stations, hotels, schools, stadiums etc.
?We are pleased to test our technology in Singapore. Through partnerships with the healthcare service providers, we hope to expand this automation system regionally. The automated system can be used for any type of lateral flow point of care and not limited to only COVID-19?, said Mr Eddie Chng, the Managing Director and CEO of DLL.
DLL has licensed the saliva-based ART kit IP from Duke-NUS Medical School and SingHealth. The kit, known as Parallel Amplified Saliva rapid POint-of-caRe Test (PASPORT), uses nanoparticles to bind the virus and uniquely. It also adds as a second type of nanoparticle that binds the first set of nanoparticles to amplify the signal. This makes testing using PASPORT more sensitive at finding and flagging the virus and allows it to be used at any time of the day, where the sensitivity of the test is not compromised even after eating or drinking. Compared to other ART, amplification enables PASPORT to be extremely sensitive. In a clinical study involving over 100 participants conducted at SGH, PASPORT?s sensitivity in detecting the virus was 97% and its specificity at 90.6%, compared to the gold standard PCR test. The invention was reviewed and published by Microchimica Acta* in November 2021.
*Microchimica Acta, established in 1937 by Fritz Pregl, is a monthly peer-reviewed scientific journal published by Springer Nature.
About Digital Life Line Pte. Ltd.
DLL, a 40% owned associate company of Disa Digital Safety Pte. Ltd., is a Singapore-based company that deals with the manufacturing and distribution of saliva-based Antigen Rapid Test (ART) kits. DLL has signed tri-party licensing agreement with National University of Singapore (?NUS?) and Singapore Health Services Pte. Ltd. (?SingHealth?) on 8 December 2021 for the use of their new saliva-based COVID-19 ART technology. This technology was co-developed by SingHealth Duke-NUS Academic Medical Centre and the NUS.
About DiSa Digital Safety Pte. Ltd.
DiSa, a wholly-owned subsidiary of DISA Limited, is a Singapore-based technology solution provider that specializes in research and development of cutting-edge digital security solution (?DiSa Asset Protection System?). With its single scan technology and seamless integration, DiSa has been able to provide item level tracking and data with no disruption to the sales process. This technology is now protecting products and categories previously unachievable with traditional serialization methods, saving millions of dollars in prevented returns.
DiSa entered the US market in 2014 launching its Smart Solutions within the largest retailer in the world with a limited store test. After rigorous testing by the Loss Prevention Research Council, USA, DiSa rolled out its Smart Solutions nationwide in 2017.
About DISA Limited
DISA Limited (SGX: 532), is a publicly-traded company on the Singapore Catalist Stock Exchange. More information is available at http://www.digital-safety.com.

 

NEWS RELEASE: DISA DIGITAL SAFETY PTE. LTD. SIGNED PROOF OF CONCEPT AGREEMENTS WITH PRIVATE HEALTHCARE SERVICE PROVIDERS TO TEST ITS AUTOMATED ANTIGEN RAPID TEST (?ART?) MACHINE- SINGAPORE ? January 20, 2022 ? Disa Digital Safety Pte. Ltd. has signed proof of concept agreements, through its 40% owned associate company, Digital Life Line Pte. Ltd. (?DLL?), with two large Singapore based private healthcare service providers to test the scalability of its patent pending Automated Antigen Rapid Test (?ART?) System (?Automated Machine?) in February 2022... https://links.sgx.com/1.0.0/corporate-announcements/G6322OQFGQL3JPQZ/698131_Disa_News%20Release_Kiosk%20POC.pdf

 

whatever will be.........will be....

 

Super powerful style of BBs here.
Wave 5 we waiting....please come by next week.
Happy Chinese New year 12/13 and end with a CNY eve reunion dinner..
Fingers Cross